Kartos Therapeutics private stock trade

Kartos Therapeutics

Legal NameKartos Therapeutics, Inc.
HeadquartersRedwood City, CA
SectorBioTech

Kartos Therapeutics is a biopharmaceutical company specializing in the development of targeted therapies for cancer treatment. It focuses on utilizing scientific research and innovative approaches to create potential cancer therapeutics. Kartos Therapeutics' expertise lies in advancing the field of oncology, with a commitment to improving treatment options and outcomes for cancer patients.

Learn more about Kartos Therapeutics IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Kartos Therapeutics, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Kartos Therapeutics, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.